Uncategorized
Remembering J. Craig Venter, PhD
Remembering J. Craig Venter, PhD
J. Craig Venter, PhD recently passed away at the age of 79 from complications following a cancer diagnosis. He was well known in both science and industry and was an integral part of sequencing the human genome in the late 90s, competing with the government organized Human Genome Project. Throughout his career, he made many other important contributions in microbiology, with the “minimal cell,” in synthetic biology, and in personalized medicine. GEN editors share anecdotes of their experiences with him, reflect on the impact that his work has had on various fields in biology, in biotech, and in how the world has responded to the disruptions caused by Venter.
Listed below are links to the GEN stories referenced in this episode of Touching Base:
Genomics Pioneer and Life Sciences Entrepreneur J. Craig Venter Dies at 79
GEN, April 30, 2026
J. Craig Venter Describes a Human Genomics Revolution Still In Progress
By J. Craig Venter, PhD, GEN, June 13, 2025
Lessons from the Minimal Cell
By Hana El-Samad, PhD, GEN, August 21, 2023
From Sequencing to Sailing: Three Decades of Adventure with Craig Venter
By Fay Lin, PhD, GEN, March 8, 2023
“Cracking the Genome”
By Kevin Davies, PhD
Touching Base Podcast
Hosted by Corinna Singleman, PhD
Behind the Breakthroughs
Hosted by Jonathan D. Grinstein, PhD
The post Remembering J. Craig Venter, PhD appeared first on GEN – Genetic Engineering and Biotechnology News.
Uncategorized
Daiichi Sankyo posts ‘extraordinary loss’ of nearly $1B
Daiichi Sankyo posts ‘extraordinary loss’ of nearly $1B
Daiichi Sankyo is scrapping plans to build antibody-drug conjugate manufacturing capacity and recorded an “extraordinary loss” of 149.4 billion Japanese yen ($950 million) after overpromising demand for its ADCs to third-party manufacturers.
The Japanese company … Read More
Uncategorized
Opinion: I’m fighting misinformation online. False hantavirus claims follow a now-familiar playbook
I learned about hantavirus misinformation this week in the same way I now learn about most public health misinformation: My followers sent it to me.
Within hours of the first headlines about a hantavirus outbreak linked to the expedition cruise ship MV Hondius, my DMs started filling with screenshots. One was from the account of a Texas doctor who became well known during Covid for promoting ivermectin. She was already telling followers that ivermectin would work against hantavirus, too.
I learned about hantavirus misinformation this week in the same way I now learn about most public health misinformation: My followers sent it to me.
Within hours of the first headlines about a hantavirus outbreak linked to the expedition cruise ship MV Hondius, my DMs started filling with screenshots. One was from the account of a Texas doctor who became well known during Covid for promoting ivermectin. She was already telling followers that ivermectin would work against hantavirus, too.
Uncategorized
Former FDA leaders, pharma speak out on mifepristone
After issuing a week-long pause on a federal appeals court decision to stop mail orders of the abortion medication mifepristone, the Supreme Court is expected to take further steps in the case by the end of the day Monday. How the court moves forward could have a major impact on the regulatory authority of the Food and Drug Administration as well as on abortion providers and patients.
“The fundamental question is: Who gets to regulate mifepristone?” said Laurie Sobel, an associate director for women’s health policy at KFF. “Can a state go further than the FDA? Is the FDA the floor or the ceiling?”
After issuing a week-long pause on a federal appeals court decision to stop mail orders of the abortion medication mifepristone, the Supreme Court is expected to take further steps in the case by the end of the day Monday. How the court moves forward could have a major impact on the regulatory authority of the Food and Drug Administration as well as on abortion providers and patients.
“The fundamental question is: Who gets to regulate mifepristone?” said Laurie Sobel, an associate director for women’s health policy at KFF. “Can a state go further than the FDA? Is the FDA the floor or the ceiling?”
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
Daiichi Sankyo posts ‘extraordinary loss’ of nearly $1B
Remembering J. Craig Venter, PhD
Opinion: I’m fighting misinformation online. False hantavirus claims follow a now-familiar playbook
Former FDA leaders, pharma speak out on mifepristone
FDA delays Leqembi decision; Artiva raises $300M; Pharvaris prices offering
ASGCT CEO David Barrett Previews the Upcoming Conference in Boston
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
-
Uncategorized9 years agoThese ’90s fashion trends are making a comeback in 2017
-
Contributors9 years ago
The final 6 ‘Game of Thrones’ episodes might feel like a full season
-
Uncategorized9 years ago
According to Dior Couture, this taboo fashion accessory is back
-
Uncategorized9 years ago
Uber and Lyft are finally available in all of New York State
-
Uncategorized9 years ago
Phillies’ Aaron Altherr makes mind-boggling barehanded play
-
Uncategorized9 years ago
The old and New Edition cast comes together to perform
-
Uncategorized9 years ago
Steph Curry finally got the contract he deserves from the Warriors
-
Uncategorized9 years ago
Disney’s live-action Aladdin finally finds its stars